Field Technologies News

81. PHARMORX Security Reveals End-to-End Product Security Solution 4/22/2009
    PHARMORX Security™, a privately held, serialization, track and trace and authentication technology services provider, reveals its flagship product, AuthentiTrack™.
82. Regulators And Pharma Companies Work Together At ISPE-IPEC Seminar To Assure Supply Chain Integrity And Address Anti-counterfeiting 4/22/2009
    ISPE, a global not-for-profit association of 25,000 pharmaceutical science and manufacturing professionals, is bringing together a strong panel of industry leaders and U.S. Food and Drug Administration (US FDA) regulators to present the Global Supply Chain Integrity and Anti-counterfeiting seminar at the ISPE 2009 Washington Seminars and Courses – Engineering Regulatory Compliance, being held at the JW Marriott in Washington, DC, USA on 1-4 June 2009.
83. Galapagos Enters Strategic Alliance In Inflammatory Diseases With Merck & Co., Inc. 4/21/2009
    Galapagos NV announced recently that it has entered into a multi-year global strategic alliance with Merck & Co., Inc., through an affiliate, to develop potential new therapies in inflammatory diseases.
84. Actavis Reintroduces Oxycodone In The US 4/21/2009
    Actavis recently announced the reintroduction by its subsidiary in the United States of Oxycodone 15 mg and 30 mg tablet products to pharmacies and customers. Oxycodone is the first product to be manufactured at Actavis’ Little Falls, NJ facility following a recently completed FDA inspection.
85. GlaxoSmithKline And Pfizer Announce Innovative Agreement To Create A New World-Leading, Specialist HIV Company 4/16/2009
    GlaxoSmithKline plc (GSK) and Pfizer Inc (PFE) announced they have entered into an agreement to create a new world-leading HIV company focused solely on research, development, and commercialisation of HIV medicines.
86. Hovione's TwinCaps Inhaler In Phase III Clinical Trials For Influenza 4/16/2009
    Hovione is pleased to announce that its licensee Daiichi Sankyo (Tokyo, Japan) has informed that it intends to use Hovione’s TwinCaps dry powder inhaler device in the launch of the compound CS-8958, an inhaled long-acting neuraminidase inhibitor active against the influenza virus.
87. Cannasat And IntelGenx Announce Positive Phase 1(b) Results Improved Buccal Tablet Outperforms Oral Dronabinol 4/15/2009
    Cannasat Therapeutics Inc. ("Cannasat") (TSX VENTURE:CTH), and its development partner IntelGenx Corp. (TSX VENTURE:IGX) (OTCBB:IGXT) ("IntelGenx"), today announced positive results for the Phase 1(b) clinical trial of Relivar, the first buccal dronabinol drug delivery product, which was developed using IntelGenx' proprietary AdVersa buccal delivery technology. Buccal delivery allows for drug absorption from the mouth directly into the bloodstream as opposed to the intestinal tract absorption seen with oral tablet technologies.
88. Tekmira Pharmaceuticals Files IND For ApoB SNALP 4/15/2009
    Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today it has filed an Investigational New Drug (IND) application seeking approval from the United States Food and Drug Administration (FDA) to begin a Phase 1 human clinical trial to evaluate the Company's lead product candidate ApoB SNALP as a treatment for elevated low-density lipoprotein (LDL) cholesterol.
89. FDA Obtains Permanent Injunction Barring Two Companies From Manufacturing And Distributing Unapproved Drugs 4/14/2009
    The U.S. Food and Drug Administration today announced that it had obtained a permanent injunction barring Neilgen Pharmaceuticals Inc. of Westminster, Md., its parent company, Advent Pharmaceuticals, Inc. (Advent), of East Windsor, N.J., and two of their officers, Bharat Patel and Pragna Patel, from manufacturing and distributing any unapproved, adulterated or misbranded drugs.
90. Lab Automation Bind - Process Automation - Bind Biosciences To Install First Siemens Simatic® PCS 7 Lab Process Control System In The U.S. 4/14/2009
    Siemens Energy & Automation, Inc. announced recently that BIND Biosciences, Inc., Cambridge, Mass., has selected Simatic® PCS 7 Lab hardware and software to help its scientists manage pre- and post-clinical experimental data.